Mupirocin ointment prevents early post-tympanostomy tube otorrhea: a preliminary study
- PMID: 24653887
- PMCID: PMC3936664
- DOI: 10.7874/kja.2012.16.3.130
Mupirocin ointment prevents early post-tympanostomy tube otorrhea: a preliminary study
Abstract
Background and objectives: The most common complication of tympanostomy tube (T-tube) insertion is the development of postoperative otorrhea. Post-tympanostomy tube otorrhea (PTTO) is defined as active drainage through an existing T-tube. Many surgeons routinely use topical antibiotics as prophylaxis against early PTTO. Mupirocin calcium ointment is a topical antimicrobial agent with broad-spectrum antimicrobial activity against many Gram-positive organisms. This study evaluated the clinical effectiveness of topical mupirocin ointment in reducing early PTTO.
Subjects and methods: The study included 98 ears (67 patients, mean age 32.9 years) that had a T-tube inserted because of chronic middle ear effusion or atelectatic otitis media. A Paparella type-I polyethylene-tube coated with mupirocin was inserted through the tympanostomy. Patients were instructed not to use otic drops or any other medications. All patients were seen by day 14 postoperatively.
Results: Early PTTO occurred in one case (1.5%). No early PTTO was seen with a middle ear effusion. Nineteen children were treated under general anesthesia; none developed early PTTO.
Conclusions: Insertion of a T-tube coated with mupirocin ointment could be effective at preventing early PTTO.
Keywords: Mupirocin; Otorrhea; Tube insertion; Tympanostomy.
Figures
Similar articles
-
The rationale for preventive treatments for early post-tympanostomy tube otorrhea in persistent otitis media with effusion.Eur Arch Otorhinolaryngol. 2016 Jun;273(6):1405-10. doi: 10.1007/s00405-015-3706-6. Epub 2015 Jul 8. Eur Arch Otorhinolaryngol. 2016. PMID: 26153378 Clinical Trial.
-
Role of Biofilms in Post-Tympanostomy Tube Otorrhea.Ear Nose Throat J. 2020 Nov;99(1_suppl):22S-29S. doi: 10.1177/0145561320914437. Epub 2020 Mar 24. Ear Nose Throat J. 2020. PMID: 32204627 Review.
-
Oxymetazoline, Mupirocin, Clotrimazole-Safe, Effective, Off-Label Agents for Tympanostomy Tube Care.Ear Nose Throat J. 2020 Nov;99(1_suppl):30S-34S. doi: 10.1177/0145561320912885. Epub 2020 Mar 17. Ear Nose Throat J. 2020. PMID: 32182136 Review.
-
Efficacy of topical 2% mupirocin ointment for treatment of tympanostomy tube otorrhea caused by community-acquired methicillin resistant Staphylococcus aureus.Int J Pediatr Otorhinolaryngol. 2018 Jun;109:36-39. doi: 10.1016/j.ijporl.2018.03.024. Epub 2018 Mar 24. Int J Pediatr Otorhinolaryngol. 2018. PMID: 29728181
-
Post-tympanostomy otorrhea: a randomized clinical trial of topical prophylaxis.Otolaryngol Head Neck Surg. 1992 Jan;106(1):34-41. doi: 10.1177/019459989210600125. Otolaryngol Head Neck Surg. 1992. PMID: 1734364 Clinical Trial.
Cited by
-
The Impact of Middle Ear Packing Material Containing Antibiotic Ointment on Postoperative Infection After Myringoplasty.J Otolaryngol Head Neck Surg. 2024 Jan-Dec;53:19160216241291810. doi: 10.1177/19160216241291810. J Otolaryngol Head Neck Surg. 2024. PMID: 39418013 Free PMC article.
References
-
- Gates GA, Avery C, Prihoda TJ, Holt GR. Post-tympanostomy otorrhea. Laryngoscope. 1986;96:630–634. - PubMed
-
- Hochman J, Blakley B, Abdoh A, Aleid H. Post-tympanostomy tube otorrhea: a meta-analysis. Otolaryngol Head Neck Surg. 2006;135:8–11. - PubMed
-
- Furukawa M, Minekawa A, Haruyama T, Narui Y, Sugita G, Sugita R, et al. Clinical effectiveness of ototopical application of mupirocin ointment in methicillin-resistant Staphylococcus aureus otorrhea. Otol Neurotol. 2008;29:676–678. - PubMed
-
- Henkel T, Finlay J. Emergence of resistance during mupirocin treatment: is it a problem in clinical practice? J Chemother. 1999;11:331–337. - PubMed
-
- Scott BA, Strunk CL., Jr Posttympanostomy otorrhea: the efficacy of canal preparation. Laryngoscope. 1992;102:1103–1107. - PubMed
LinkOut - more resources
Full Text Sources